ArticleInternational journal of clinical oncology2025

Predictors of early progressive disease and antitumor effects by metastatic site in renal cell carcinoma treated with ipilimumab plus nivolumab.

Keiichiro Mori et al.PubMed ↗Publisher ↗

No numbers read from the abstract.